Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis

J Friess, M Hecker, L Roch, D Koczan, B Fitzner… - Scientific reports, 2017 - nature.com
Multiple sclerosis is a demyelinating disease affecting the central nervous system. T cells
are known to contribute to this immune-mediated condition. Fingolimod modulates
sphingosine-1-phosphate receptors, thereby preventing the egress of lymphocytes,
especially CCR7-expressing CD8+ and CD4+ T cells, from lymphoid tissues. Using
Affymetrix Human Transcriptome Arrays (HTA 2.0), we performed a transcriptome profiling
analysis of CD4+ cells obtained from the peripheral blood of patients with highly active …

[引用][C] Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis. Sci Rep 7: 42087

J Friess, M Hecker, L Roch, D Koczan, B Fitzner… - 2017
以上显示的是最相近的搜索结果。 查看全部搜索结果